title: Cell-free antigens from Paracoccidioides brasiliensis drive IL-4 production and increase the severity of paracoccidioidomycosis.
abstract: The thermally dimorphic fungus Paracoccidioides brasiliensis (Pb) is the causative agent of paracoccidioidomycosis (PCM), one of the most frequent systemic mycosis that affects the rural population in Latin America. PCM is characterized by a chronic inflammatory granulomatous reaction, which is consequence of a Th1-mediated adaptive immune response. In the present study we investigated the mechanisms involved in the immunoregulation triggered after a prior contact with cell-free antigens (CFA) during a murine model of PCM. The results showed that the inoculation of CFA prior to the infection resulted in disorganized granulomatous lesions and increased fungal replication in the lungs, liver and spleen, that paralleled with the higher levels of IL-4 when compared with the control group. The role of IL-4 in facilitating the fungal growth was demonstrated in IL-4-deficient- and neutralizing anti-IL-4 mAb-treated mice. The injection of CFA did not affect the fungal growth in these mice, which, in fact, exhibited a significant diminished amount of fungus in the tissues and smaller granulomas. Considering that in vivo anti-IL-4-application started one week after the CFA-inoculum, it implicates that IL-4-CFA-induced is responsible by the mediation of the observed unresponsiveness. Further, the characterization of CFA indicated that a proteic fraction is required for triggering the immunosuppressive mechanisms, while glycosylation or glycosphingolipids moieties are not. Taken together, our data suggest that the prior contact with soluble Pb antigens leads to severe PCM in an IL-4 dependent manner.
authors: School of Medicine of Ribeirao Preto, São Paulo University, Ribeirao Preto, São Paulo, Brazil.
authors: Karen A
authors: KA
authors: Cavassani
authors: Fabrine S M
authors: FS
authors: Tristao
authors: Leandro L
authors: LL
authors: Oliveira
authors: Fernanda A
authors: FA
authors: Rocha
authors: Jaqueline O
authors: JO
authors: Vancim
authors: Ana Paula
authors: AP
authors: Moreira
authors: Ana Paula
authors: AP
authors: Campanelli
authors: Luciano A
authors: LA
authors: Panagio
authors: Cristiane M
authors: CM
authors: Milanezi
authors: Roberto
authors: R
authors: Martinez
authors: Marcos A
authors: MA
authors: Rossi
authors: Joao S
authors: JS
authors: Silva
mesh_terms: D000818:Animals; D000946:Antigens, Fungal / Q000276:immunology*; D005620:Freund's Adjuvant / Q000494:pharmacology; D006099:Granuloma / Q000473:pathology; D007165:Immunosuppression Therapy; D016753:Interleukin-10 / Q000378:metabolism; D015847:Interleukin-4 / Q000096:biosynthesis* / Q000172:deficiency; D008168:Lung / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D051379:Mice; D009500:Neutralization Tests; D010228:Paracoccidioides / Q000187:drug effects / Q000254:growth & development / Q000276:immunology*; D010229:Paracoccidioidomycosis / Q000276:immunology* / Q000382:microbiology* / Q000473:pathology
chemical_list: D000946:Antigens, Fungal; D016753:Interleukin-10; D015847:Interleukin-4; D005620:Freund's Adjuvant